Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Molecular Cancer|July 30, 2009
PIK3CA alterations in Middle Eastern ovarian cancersJehad Abubaker, Prashant Bavi, Wael Al-Haqawi, et al.Leukemia & Lymphoma|March 9, 2012
Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphomaRong Bu, Prashant Bavi, Jehad Abubaker, et al.Human Mutation|March 3, 2019
Prevalence, spectrum, and founder effect of BRCA1 and BRCA2 mutations in epithelial ovarian cancer from the Middle EastAbdul K Siraj, Rong Bu, Kaleem Iqbal, et al.Endocrine|May 2, 2024
Predicting factors and clinical outcome of biochemical incomplete response in middle eastern differentiated thyroid carcinomaSandeep Kumar Parvathareddy, Abdul K Siraj, Saeeda O Ahmed, et al.Scientific Reports|July 30, 2022
Exome sequencing revealed comparable frequencies of RNF43 and BRAF mutations in Middle Eastern colorectal cancerAbdul Khalid Siraj, Rong Bu, Tariq Masoodi, et al.The Journal of Pathology|October 14, 2009
Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinomaJehad Abubaker, Prashant Bavi, Wael Al-Haqawi, et al.Frontiers in Endocrinology|October 23, 2023
Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi ArabiaSandeep Kumar Parvathareddy, Abdul K Siraj, Padmanaban Annaiyappanaidu, et al.Frontiers in Endocrinology|December 29, 2022
X-linked inhibitor of apoptosis protein (XIAP) predicts disease-free survival in BRAFV600E mutant papillary thyroid carcinoma in middle eastern patientsSandeep Kumar Parvathareddy, Abdul K Siraj, Rong Bu, et al.Genomics|November 1, 2019
Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern populationAbdul K Siraj, Rong Bu, Kaleem Iqbal, et al.Pageof 1